维普中文期刊产品整合服务
78篇 您的检索式:作者名="PATRICIA A L"
    题名 作者 年代 出处 被引量
1Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy显示文摘AIM To determine influence of neoadjuvant-chemotherapy(NAC) over tumor-infiltrating-lymphocytes(TIL) intriple-negative-breast-cancer(TNBC).METHODS TILs were evaluated in 98 TNBC cases who came to Instituto Nacional de Enfermedades Neoplasicas from 2005 to 2010. Immunohistochemistry staining for CD3, CD4, CD8 and FOXP3 was performed in tissue microarrays(TMA) sections. Evaluation of H/E in full-face and immunohistochemistry in TMA sections was performed in pre and post-NAC samples. STATA software was used and P value < 0.05 was considered statistically significant. RESULTS Higher TIL evaluated in full-face sections from pre-NAC tumors was associated to pathologic-complete-response(pCR)(P = 0.0251) and outcome(P = 0.0334). TIL evaluated in TMA sections showed low level of agreement with full-face sections(ICC = 0.017-0.20) and was not associated to pCR or outcome. TIL in post-NAC samples were not associated to response or outcome. PostNAC lesions with pC R had similar TIL levels than those without pCR(P = 0.6331). NAC produced a TIL decrease in full-face sections(P < 0.0001). Percentage of TIL subpopulations was correlated with their absolute counts. Higher counts of CD3, CD4, CD8 and FOXP3 in pre-NAC samples had longer disease-free-survival(DFS). Higher counts of CD3 in pre-NAC samples had longer overallsurvival. Higher ratio of CD8/CD4 counts in pre-NAC was associated with pCR. Higher ratio of CD4/FOXP3 counts in pre-NAC was associated with longer DFS. Higher counts of CD4 in post-NAC samples were associated with pCR.CONCLUSION TIL in pre-NAC full-face sections in TNBC are correlated to longer survival. TIL in full-face differ from TMA sections, absolute count and percentage analysis of TIL subpopulation closely related.Carlos A Castaneda Elizabeth Mittendorf Sandro Casavilca Yun Wu Miluska Castillo Patricia Arboleda Teresa Nunez Henry Guerra Carlos Barrionuevo Ketty Dolores-Cerna Carolina Belmar-Lopez Julio Abugattas Gabriela Calderon Miguel De La Cruz Manuel Cotrina Jorge Dunstan Henry L Gomez Tatiana Vidaurre 2016World Journal of Clinical Oncology2016,7,5:6
2National natural capital accounting with the ecological footprint concept显示文摘Mathis Wackernagel Larry Onisto Patricia Bello Alejandro Callejas Linares Ina Susana López Falfán Jesus Méndez Garc??a Ana Isabel Suárez Guerrero Ma Guadalupe Suárez Guerrero 1999Ecological Economics1999,,3:5
3National natural capital accounting with the ecological footprint concept显示文摘Mathis Wackernagel Larry Onisto Patricia Bello Alejandro Callejas Linares Ina Susana López Falfán Jesus Méndez Garc??a Ana Isabel Suárez Guerrero Ma Guadalupe Suárez Guerrero 1999Ecological Economics1999,,3:3
4Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett’s oesophagus: a prospective study显示文摘Thomas L Vaughan Linda M Dong Patricia L Blount Kamran Ayub Robert D Odze Carissa A Sanchez Peter S Rabinovitch Brian J Reid 2005Lancet Oncology2005,,12:2
5Predictors of progression in Barrett’s esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression显示文摘Brian J Reid Laura J Prevo Patricia C Galipeau Carissa A Sanchez Gary Longton Douglas S Levine Patricia L Blount Peter S Rabinovitch 2001The American Journal of Gastroenterology2001,,10:2
6Silent diabetic nephropathy显示文摘AIM: To examine the risk of renal events in patients with biopsy-proven diabetic nephropathy(DN) and its possible associated factors.METHODS: Clinical and histological data of 60 patients diagnosed with diabetic nephropathy were retrospectively collected. Patients with evidence or suspicion of other nephropathies were excluded from the study. The final event was defined as renal replacement therapy(RRT) initiation or progression of chronic kidney disease(CKD), according to the KDIGO 2012 definition of a decrease in CKD category and a decrease in GFR of 25% or more. RESULTS: A total of 45 patients with a follow-up of at least 3 mo were included. Most of the patients presented type 2 DM, with a median age of 58.3 years old. The time of evolution of DM was 9.6 ± 7.8 years, although in 13 patients, it was less than 5 years. A total of 62% of patients reached the final event in a mean period of 3.4 years(95%CI: 2.1-4.7), with 21 of them requiring dialysis. The factors that were independently associated with renal survival were estimated glomerular filtration rate(e GFR) at the time of biopsy, cardiovascular disease(CVD) history and Hb A1 c less than 7%. Therefore, for each 10 m L/min per 1.73 m2 reduction in e GFR, we obtained a DN progression risk of HR = 2(1.3-3.0)(P = 0.001); patients with CVD were at greater risk for DN progression(HR = 2.8, 1.1-7.1, P = 0.032), and CKD patients with Hb A1 c < 7% demonstrated greater renal risk than patients with Hb A1 c ≥ 7%, with an HR of 2.9(1.0-8.4)(P = 0.054).CONCLUSION: A past history of CVD is a risk factor for DN progression. Levels of Hb A1 c less than 7% could favor an e GFR decrease in these patients.Katia López-Revuelta Patricia Pea Galdo Ramona Stanescu Leticia Parejo Carmen Guerrero Elia Pérez-Fernández 2014World Journal of Nephrology2014,3,1:2
7Quality of Life in Long - Term, Disease- Free Survivors of Breast Cancer: a Follow - up Study 显示文摘Patricia A G Katherine A D Beth L 2002J Natl Cancer Inst2002,94,1:1
8Effects of activated carbon characteristics on the simultaneous adsorption of aqueous organic micropollutants and natural organic matter 显示文摘Patricia A Q Li L Detlef R U 2005Water Research2005,39,8:1
9Probabilistic approach for determining Salmonella spp. and L. monocytogenes concentration in pork meat from presence/absence microbiological data显示文摘Antonio Valero Marta Hernandez Alessandra De Cesare Gerardo Manfreda Rosa Maria García-Gimeno Patricia González-García David Rodríguez Lázaro 2014International Journal of Food Microbiology2014,,:1
10Interferon regulatory factors: growth control and histone gene regulation-it' s not just interferon anymore 显示文摘Patricia S Vaughan A J Wijnen J L 1997Mol Med1997,75,:1
11Using social stories and comic strip conversations to promote socially valid outcomes for children with autism显示文摘 Hutchins Patricia A 2006Seminars in Speech and Language2006,27,1:1
12Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy显示文摘Juan Macías Manuel Márquez Francisco Téllez Dolores Merino Patricia Jiménez-Aguilar Luis F. López-Cortés Enrique Ortega Miguel A. von Wichmann Antonio Rivero María Mancebo Jesús Santos Montserrat Pérez-Pérez Ignacio Suárez-Lozano Alberto Romero-Palacios A 2013Clinical Infectious Diseases2013,,10:1
13查看详情显示文摘María L G P Patricia P B Roberto R G José L M V Antonia G F 0,,27:1
14Antigenic diversity in Eimeria maxima and the influence of host genetics and immunization schedule on cross-protective immunity显示文摘Adrian L S Patricia H Andrew A 2002Infect Immun2002,70,5:1
15Influence of Modified Atmosphere Packaging on Sensory Quality of Shiitake Mushrooms显示文摘GABRIELA A GASTCDN A PATRICIA L 2008Postharvest Biology and Technology2008,49,1:1
16Attachment-based assessments of parent-child relationships in middle childhood显示文摘Kathryn A Kerns Patricia L 2000Developm Psychol2000,36,5:1
17Survey of psychopharmacy curric ula and faculty at schools of pharmacy 显示文摘 Marken R Evans L 1993Am J Pharm Educ1993,57,:1
18Direct anal ysis of antarctic krill by slurry sampling: determination of copper, iron, manganese and zinc by flame atomic absorption spectrometry显示文摘FLAVIA L A PATRICIA S SILVIA F 2000Journal of the Brazilian Chemical Society2000,11,4:1
19Mycoplasma genitalium among women with nongonococcal nonchlamydial pelvic inflammatory disease 显示文摘Catherine L H Patricia A T 3 Sabina GA 2006Infectious Diseases in Obstetrics and Gynecology2006,30,184:1
20Role ofdobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease显示文摘Seng-chye C Patricia A Veronique L 1998Circulation1998,97,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费